Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AilsynBio is a synthetic biology company specializing in the development and manufacturing of high-value chemicals, pharmaceutical intermediates, and nutritional ingredients. Utilizing advanced enzyme engineering and metabolic pathway optimization, the company provides sustainable bio-manufacturing solutions as an alternative to traditional chemical synthesis. AilsynBio operates as a platform-driven entity, offering CDMO services to the pharmaceutical and healthcare industries for complex molecule production. Their technology focuses on improving production efficiency and reducing environmental impact through green chemistry principles. The company's portfolio includes products such as Nicotinamide Mononucleotide (NMN) and various specialty amino acids.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AilsynBio.